Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 06 04:00PM ET
28.62
Dollar change
+0.22
Percentage change
0.77
%
IndexRUT P/E- EPS (ttm)-2.22 Insider Own57.66% Shs Outstand146.57M Perf Week1.49%
Market Cap4.23B Forward P/E- EPS next Y-3.13 Insider Trans-0.18% Shs Float62.13M Perf Month-8.91%
Income-323.01M PEG- EPS next Q-0.73 Inst Own53.54% Short Float20.95% Perf Quarter-8.97%
Sales0.00M P/S- EPS this Y-51.82% Inst Trans6.67% Short Ratio14.84 Perf Half Y13.71%
Book/sh3.06 P/B9.34 EPS next Y-9.66% ROA-79.97% Short Interest13.02M Perf Year-26.65%
Cash/sh3.20 P/C8.95 EPS next 5Y3.69% ROE-92.17% 52W Range24.61 - 45.58 Perf YTD-32.07%
Dividend Est.- P/FCF- EPS past 5Y- ROI-71.93% 52W High-37.21% Beta0.63
Dividend TTM- Quick Ratio7.61 Sales past 5Y0.00% Gross Margin- 52W Low16.29% ATR (14)1.12
Dividend Ex-Date- Current Ratio7.61 EPS Y/Y TTM-12.81% Oper. Margin- RSI (14)51.83 Volatility2.98% 4.37%
Employees207 Debt/Eq0.00 Sales Y/Y TTM- Profit Margin- Recom1.07 Target Price49.50
Option/ShortYes / Yes LT Debt/Eq0.00 EPS Q/Q-66.55% Payout- Rel Volume1.05 Prev Close28.40
Sales Surprise- EPS Surprise-10.95% Sales Q/Q- EarningsNov 07 BMO Avg Volume877.29K Price28.62
SMA202.49% SMA50-1.14% SMA200-2.99% Trades Volume919,836 Change0.77%
Date Action Analyst Rating Change Price Target Change
Oct-10-24Resumed Raymond James Outperform $36
Oct-09-24Reiterated Oppenheimer Outperform $47 → $53
Mar-28-24Initiated Oppenheimer Outperform $50
Mar-13-24Initiated Goldman Buy $50
Feb-20-24Initiated JP Morgan Overweight $51
Feb-15-24Initiated Wolfe Research Outperform $55
Dec-12-23Initiated Deutsche Bank Buy $50
Oct-13-23Upgrade UBS Neutral → Buy $18 → $55
Sep-26-23Upgrade Raymond James Mkt Perform → Outperform $40
May-01-23Initiated BofA Securities Buy $26
Nov-21-24 05:31PM
Nov-13-24 03:05AM
Nov-07-24 06:30AM
Oct-29-24 06:30AM
Oct-01-24 09:58AM
11:12AM Loading…
Sep-30-24 11:12AM
Sep-09-24 12:54PM
09:13AM
07:00AM
03:55AM
Sep-05-24 11:31AM
06:30AM
Aug-09-24 12:20AM
Aug-06-24 04:05PM
Jun-28-24 11:30AM
08:04AM Loading…
May-31-24 08:04AM
02:26AM
May-30-24 04:02PM
11:29AM
07:22AM
05:53AM
May-29-24 09:53PM
04:06PM
04:01PM
10:17AM
May-27-24 06:28PM
May-13-24 09:55AM
May-08-24 02:43AM
Apr-24-24 11:33AM
07:39AM
11:53AM Loading…
Apr-22-24 11:53AM
Apr-17-24 12:00PM
Mar-25-24 03:00PM
Mar-21-24 04:45PM
11:31AM
Mar-17-24 05:20PM
Mar-14-24 07:04AM
Mar-13-24 11:30AM
Mar-12-24 07:30AM
Mar-08-24 09:35AM
Feb-26-24 03:04PM
Feb-23-24 11:22PM
Feb-14-24 04:35AM
12:29AM
Feb-13-24 07:26AM
Feb-12-24 07:00AM
Feb-06-24 02:38PM
Jan-22-24 06:07AM
Jan-19-24 04:39PM
Jan-13-24 03:02AM
Jan-03-24 08:00AM
Dec-26-23 10:01AM
Dec-21-23 04:09PM
11:00AM
10:57AM
06:49AM
Dec-20-23 04:30PM
04:30PM
Dec-19-23 10:16AM
Dec-01-23 01:01AM
Nov-29-23 10:22AM
Nov-28-23 07:00AM
07:00AM
Nov-25-23 11:03AM
Nov-14-23 12:30AM
Nov-13-23 08:00AM
Nov-10-23 07:19AM
Nov-09-23 08:17AM
07:00AM
Oct-27-23 11:02PM
Oct-13-23 09:50AM
Oct-11-23 11:01PM
Oct-07-23 01:00AM
Oct-05-23 03:01AM
Oct-02-23 04:52PM
Sep-28-23 09:58AM
Sep-27-23 11:41PM
04:09PM
04:06PM
12:25PM
12:21PM
09:25AM
Sep-26-23 05:00PM
04:13PM
04:06PM
03:23PM
02:26PM
10:01AM
09:10AM
06:00AM
Sep-25-23 11:01PM
Aug-17-23 09:31AM
Aug-12-23 08:25AM
Aug-11-23 11:20AM
Aug-10-23 07:00AM
Aug-09-23 06:26AM
Aug-01-23 10:00AM
Jul-03-23 09:00AM
Jul-01-23 09:00AM
Jun-29-23 01:42AM
Immunovant, Inc. is a clinical-stage biopharmaceutical company, which focuses on enabling normal lives for patients with autoimmune diseases. It is developing a novel, fully human monoclonal antibody IMVT-1401 that selectively binds to and inhibits the neonatal fragment crystallizable receptor. The company was founded in 2018 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Pande AtulDirectorDec 02 '24Sale28.547,750221,18586,663Dec 04 04:22 PM
Hughes Douglas J.DirectorDec 02 '24Sale28.545,425154,830119,585Dec 04 04:20 PM
DOUGLAS J. HUGHESOfficerDec 02 '24Proposed Sale28.205,425152,985Dec 02 04:33 PM
ATUL CHANDRA PANDEDirectorDec 02 '24Proposed Sale28.207,750218,550Dec 02 04:33 PM
Levine Mark S.Chief Legal OfficerNov 20 '24Sale25.453,65092,892319,228Nov 22 04:12 PM
Macias William L.Chief Medical OfficerNov 20 '24Sale25.453,35385,334361,791Nov 22 04:11 PM
Barnett Eva ReneeChief Financial OfficerNov 20 '24Sale25.454,174106,228331,169Nov 22 04:09 PM
Salzmann PeterChief Executive OfficerNov 20 '24Sale25.4516,692424,811978,097Nov 22 04:08 PM
Levine Mark S.Chief Legal OfficerOct 23 '24Sale29.534,361128,780322,878Oct 25 04:25 PM
Geffner MichaelChief Medical OfficerOct 23 '24Sale29.533,18994,171134,971Oct 25 04:23 PM
Stout Jay SChief Technology OfficerOct 23 '24Sale29.532,74080,912142,186Oct 25 04:21 PM
Salzmann PeterChief Executive OfficerOct 16 '24Sale28.799,095261,845994,789Oct 18 04:31 PM
Macias William L.Chief Medical OfficerOct 16 '24Sale28.793,18891,783365,144Oct 18 04:30 PM
Levine Mark S.Chief Legal OfficerOct 16 '24Sale28.792,86082,339327,239Oct 18 04:28 PM
Barnett Eva ReneeChief Financial OfficerOct 16 '24Sale28.793,27194,172335,343Oct 18 04:27 PM
Barnett Eva ReneeChief Financial OfficerOct 09 '24Sale29.565,162152,589338,614Oct 11 04:04 PM
Salzmann PeterChief Executive OfficerOct 09 '24Sale29.564,460131,8381,003,884Oct 11 04:02 PM
Levine Mark S.Chief Legal OfficerAug 21 '24Sale31.863,295104,976330,099Aug 23 04:15 PM
Macias William L.Chief Medical OfficerAug 21 '24Sale31.863,02796,437368,332Aug 23 04:14 PM
Barnett Eva ReneeChief Financial OfficerAug 21 '24Sale31.863,768120,045343,776Aug 23 04:11 PM
Butchko Julia G.Chief Development OfficerAug 21 '24Sale31.863,02796,437440,959Aug 23 04:10 PM
Salzmann PeterChief Executive OfficerAug 21 '24Sale31.8615,068480,0521,008,344Aug 23 04:07 PM
Stout Jay SChief Technology OfficerJul 24 '24Sale27.762,81378,089144,926Jul 26 04:20 PM
Geffner MichaelChief Medical OfficerJul 24 '24Sale27.763,45695,939138,160Jul 26 04:19 PM
Levine Mark S.Chief Legal OfficerJul 24 '24Sale27.764,015111,456333,394Jul 26 04:17 PM
Levine Mark S.Chief Legal OfficerJul 17 '24Sale29.692,50574,382337,409Jul 19 05:42 PM
Macias William L.Chief Medical OfficerJul 17 '24Sale29.693,04490,386371,359Jul 19 05:41 PM
Barnett Eva ReneeChief Financial OfficerJul 17 '24Sale29.693,12392,733347,544Jul 19 05:39 PM
Butchko Julia G.Chief Development OfficerJul 17 '24Sale29.692,86785,132443,986Jul 19 05:38 PM
Salzmann PeterChief Executive OfficerJul 17 '24Sale29.698,685257,8871,023,412Jul 19 05:36 PM
Barnett Eva ReneeChief Financial OfficerJul 09 '24Sale28.064,747133,201350,667Jul 10 05:07 PM
Butchko Julia G.Chief Development OfficerJul 09 '24Sale28.061,52742,848446,853Jul 10 05:06 PM
Salzmann PeterChief Executive OfficerJul 09 '24Sale28.064,619129,6091,032,097Jul 10 05:04 PM
Barnett Eva ReneeChief Financial OfficerMay 22 '24Sale29.654,042119,845355,414May 24 04:18 PM
Salzmann PeterChief Executive OfficerMay 22 '24Sale29.6516,163479,2331,036,716May 24 04:15 PM
Butchko Julia G.Chief Development OfficerMay 22 '24Sale29.653,24796,274448,380May 24 04:14 PM
Macias William L.Chief Medical OfficerMay 22 '24Sale29.653,24796,274374,403May 24 04:13 PM
Levine Mark S.Chief Legal OfficerMay 22 '24Sale29.653,24296,125339,914May 24 04:10 PM
Geffner MichaelChief Medical OfficerApr 24 '24Sale28.903,26194,243141,616Apr 26 05:22 PM
Stout Jay SChief Technology OfficerApr 24 '24Sale28.907,239209,207147,739Apr 26 05:20 PM
Levine Mark S.Chief Legal OfficerApr 24 '24Sale28.903,963114,531343,156Apr 26 05:18 PM
Levine Mark S.Chief Legal OfficerApr 17 '24Sale29.069,827285,554347,119Apr 19 06:06 PM
Macias William L.Chief Medical OfficerApr 17 '24Sale29.068,280240,602377,650Apr 19 06:05 PM
Barnett Eva ReneeChief Financial OfficerApr 17 '24Sale29.0612,253356,049359,456Apr 19 06:01 PM
Butchko Julia G.Chief Development OfficerApr 17 '24Sale29.0610,115293,923451,627Apr 19 05:59 PM
Salzmann PeterChief Executive OfficerApr 17 '24Sale29.0634,079990,2691,052,879Apr 19 05:57 PM
Barnett Eva ReneeChief Financial OfficerApr 09 '24Sale31.183,689115,023371,709Apr 10 04:18 PM
Butchko Julia G.Chief Development OfficerApr 09 '24Sale31.181,05332,833461,742Apr 10 04:16 PM
Salzmann PeterChief Executive OfficerApr 09 '24Sale31.184,807149,8821,086,958Apr 10 04:14 PM
Barnett Eva ReneeChief Financial OfficerFeb 22 '24Sale36.152,930105,920320,420Feb 23 04:21 PM
Levine Mark S.Chief Legal OfficerFeb 22 '24Sale36.152,13477,144301,968Feb 23 04:18 PM
Macias William L.Chief Medical OfficerFeb 22 '24Sale36.152,22180,289330,952Feb 23 04:16 PM
Butchko Julia G.Chief Development OfficerFeb 22 '24Sale36.152,14677,578407,817Feb 23 04:14 PM
Salzmann PeterChief Executive OfficerFeb 22 '24Sale36.1513,454486,362931,231Feb 23 04:11 PM
Levine Mark S.Chief Legal OfficerJan 26 '24Sale37.923,027114,778304,102Jan 29 04:12 PM
Geffner MichaelChief Medical OfficerJan 26 '24Sale37.9210,101383,01289,899Jan 29 04:11 PM
Macias William L.Chief Medical OfficerJan 18 '24Sale41.0342417,397333,173Jan 19 04:04 PM
Barnett Eva ReneeChief Financial OfficerJan 11 '24Sale41.833,515147,023323,350Jan 12 04:34 PM
Butchko Julia G.Chief Development OfficerJan 05 '24Sale38.591,29750,051409,963Jan 09 04:20 PM
Salzmann PeterChief Executive OfficerJan 05 '24Sale38.593,824147,568944,685Jan 09 04:18 PM